Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.36 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8773721 | 1.00 | TSHR (0.38) | TSHRZDHHC20ZDHHC2MAPTLMNA | |
| SCHEMBL6914555 | 0.84 | PLA2G1B (0.38) | TSHRLMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL5702641 | 0.78 | TSHR (0.37) | TSHRLMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL9333397 | 0.78 | TSHR (0.37) | TSHRLMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL6544383 | 0.74 | CYP1A2 (0.36) | TSHR | |
| SCHEMBL5481491 | 0.71 | TSHR (0.39) | TSHRZDHHC20ZDHHC2MAPTLMNA | |
| SCHEMBL23388971 | 0.70 | TSHR (0.42) | TSHRDNM1 | |
| SCHEMBL12844942 | 0.69 | TSHR (0.46) | TSHRZDHHC20ZDHHC2MAPTLMNA | |
| SCHEMBL4745188 | 0.69 | TSHR (0.46) | TSHRZDHHC20ZDHHC2MAPTLMNA | |
| SCHEMBL15211724 | 0.69 | TSHR (0.46) | TSHRZDHHC20ZDHHC2MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1005447-B1 | METHOD FOR PRODUCING LONG-CHAIN GLYCINE-N,N-DIACETIC ACID DERIVATIVES | BASF AG (DE) | 2003-04-23 | — | — | EP | disclosed |
| US-6420593-B2 | COMPRISES REACTING IMINODIACETONITRILE WITH ALDEHYDES AND HYDROGEN CYANIDE OR ALKALI METAL CYANIDES; USEFUL AS BIODEGRADABLE COMPLEXING AGENTS FOR ALKALI METAL AND HEAVY METAL IONS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-16 | — | — | US | disclosed |
| US-20010034457-A1 | Method for producing long-chain glycine-N,N-diacetic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-25 | — | — | US | disclosed |
| US-6307086-B1 | PREPARATION OF LONG-CHAIN SUBSTITUTED NITRILOTRIACETONITRILES FROM IMINODIACETONITRILE, LONG-CHAIN ALDEHYDE AND HCN OR ALKALI METAL CYANIDE OR FROM AN ALPHA-AMINO LONG-CHAIN NITRILE, FORMALDEHYDE AND HCN OR ALKALI METAL CYANIDE | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034457-A1 | Method for producing long-chain glycine-N,N-diacetic acid derivatives | SCO2, HAO2, CLIC1 | TSHR 4699/4885ZDHHC20 1981/4885ZDHHC2 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.